What is the proper counselling for a patient using bimatoprost (prostaglandin analog) eye drops?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Patient Counseling for Bimatoprost Eye Drops

Patients using bimatoprost drops must be counseled about proper administration technique, potential permanent iris pigmentation, eyelash changes, and the critical importance of daily adherence to prevent vision loss from glaucoma progression.

Administration Technique

Proper Instillation Method

  • Instruct patients to avoid allowing the bottle tip to contact the eye, surrounding structures, fingers, or any other surface to prevent contamination that could lead to serious ocular infections and vision loss 1.
  • Teach patients eyelid closure or nasolacrimal occlusion (pressing on the inner corner of the eye) after instillation to reduce systemic absorption 2.
  • Provide repeated instruction and counseling about proper drop instillation techniques, as many patients struggle with correct administration, particularly with aging and visual impairment 2.

Timing and Combination Therapy

  • Administer bimatoprost once daily, typically in the evening 3.
  • If using multiple eye drops, wait at least 5 minutes between different medications 1.
  • Link drop administration to daily activities (bedtime routine, morning coffee) to improve adherence 2.

Critical Side Effects and Appearance Changes

Permanent Pigmentation Risk

  • Warn patients about potential permanent increased brown pigmentation of the iris, which may not reverse after stopping the medication 1.
  • Inform patients about possible eyelid skin darkening, which is typically reversible after discontinuation 1.

Eyelash Changes

  • Counsel patients about eyelash and vellus hair changes including increased length, thickness, pigmentation, number, and altered growth direction 1.
  • Explain that these changes may create asymmetry between eyes and are usually reversible upon discontinuation 1.
  • Note that while cosmetically concerning to some, these changes are generally well-tolerated 3, 4.

Conjunctival Hyperemia

  • Inform patients that mild to moderate eye redness occurs in 42-46% of users but is usually mild 3.
  • Reassure that only 1-4% discontinue due to this side effect 3.

Contact Lens Considerations

  • Remove contact lenses before instilling bimatoprost because the preservative benzalkonium chloride can be absorbed by soft lenses 1.
  • Wait 15 minutes after administration before reinserting lenses 1.

When to Seek Medical Attention

Patients must immediately contact their physician if they develop:

  • Any intercurrent ocular condition such as eye trauma or infection 1
  • Ocular surgery 1
  • Conjunctivitis or eyelid reactions 1

Adherence Counseling

Emphasize Critical Importance

  • Stress that nearly 45% of glaucoma patients take fewer than 75% of prescribed doses, leading to inadequate IOP control and preventable vision loss 2, 5.
  • Explain that glaucoma damage is irreversible, making consistent daily use essential for preventing blindness 2.

Practical Adherence Strategies

  • Provide a clearly written medication schedule 2.
  • Suggest smartphone reminders or alarms 2.
  • Review the specific time of day medication is taken at each visit to reinforce routine 2.
  • Discuss cost concerns openly, as this significantly impacts adherence 2.
  • Address physical limitations in drop instillation, particularly in patients with visual acuity worse than 20/70 2.

Special Populations

Pregnancy and Breastfeeding

  • Bimatoprost is Pregnancy Category C and should generally be avoided during pregnancy due to theoretical risk of premature labor, though limited data exists 2.
  • May be considered during breastfeeding with caution 2.
  • Requires interdisciplinary discussion balancing maternal glaucoma progression risk against fetal/infant safety 2.

Storage and Handling

  • Store at 2°C to 25°C (36°F to 77°F) 1.
  • Can be used until expiration date after opening 1.
  • Check that tamper-evident ring is intact before first use 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Improving Medication Dosing Compliance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.